Cancer Health Treatment Update Reporter's Notebook: Cancer Researchers Confront Racism, COVID-19 The American Association for Cancer Research Annual Meeting goes virtual. Women Taking Statins Have Lower Ovarian Cancer Death Rate Cholesterol-lowering medications were associated with at least a 40% reduction in mortality. Physicians Need to Better Document Sexual Orientation and Gender Identity By recording such details, clinicians can aid in improving LGBTQIA+ health disparities, argues a researcher. Too Much Sitting Linked to Higher Risk of Cancer Death Replacing 30 minutes of sedentary time with physical activity can reduce that risk, study shows. COVID-19 and Cancer Expose Society’s Health Care Gaps Researchers work to disrupt health disparities and misinformation as coronavirus ravages the medically underserved. For all of Cancer Health's coverage of the novel coronavirus and COVID-19, including how they affect people living with cancer, click here. News From the ASCO Annual Meeting See all our reports from the American Society of Clinical Oncology's virtual scientific program. Cancer Health Summer 2020 Check out our new print edition! Advertisement Newsfeed How to Grill Safely in the Summer Building Genetic Diversity Into Cancer Research New Guidelines for Cancer Prevention Too Much Sitting Linked to Higher Risk of Cancer Death Blog: Food and Drug Administration (FDA) FDA Approves Opdivo for Esophageal Cancer FDA Approves Cyramza Plus Tarceva for First-Line Lung Cancer Treatment FDA Approves Opdivo Plus Yervoy With Chemotherapy for Metastatic Lung Cancer FDA Approves Alunbrig for ALK-Positive Metastatic Non-Small-Cell Lung Cancer Newsfeed How to Grill Safely in the Summer Building Genetic Diversity Into Cancer Research New Guidelines for Cancer Prevention Too Much Sitting Linked to Higher Risk of Cancer Death Blog: Food and Drug Administration (FDA) FDA Approves Opdivo for Esophageal Cancer FDA Approves Cyramza Plus Tarceva for First-Line Lung Cancer Treatment FDA Approves Opdivo Plus Yervoy With Chemotherapy for Metastatic Lung Cancer FDA Approves Alunbrig for ALK-Positive Metastatic Non-Small-Cell Lung Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: